Bank Of Montreal Amicus Therapeutics, Inc. Transaction History

Bank Of Montreal

$197 Billion
Q2 2024

A detailed history of Bank Of Montreal transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 107,369 shares of FOLD stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,369

Holding current value

$1.21 Million

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $970,615 - $1.26 Million	107,369 New	107,369 $1.07 Million
Q2 2023 Aug 02, 2023	BUY	$10.72 - $13.3 $11,802 - $14,643	1,101 Added 0.38%	290,517 $3.65 Million
Q1 2023 Jun 13, 2024	BUY	$10.91 - $13.54 $3.28 Million - $4.07 Million	300,836 New	300,836 $3.34 Million
Q4 2022 Feb 01, 2023	SELL	$9.89 - $12.7 $10,819 - $13,893	-1,094 Reduced 0.38%	289,416 $3.53 Million
Q3 2022 Nov 10, 2022	SELL	$9.82 - $12.75 $3.34 Million - $4.34 Million	-340,213 Reduced 53.94%	290,510 $3.04 Million
Q2 2022 Aug 11, 2022	BUY	$6.23 - $11.12 $1.68 Million - $3.01 Million	270,318 Added 75.0%	630,723 $7.01 Million
Q1 2022 May 12, 2022	SELL	$7.89 - $12.48 $68,422 - $108,226	-8,672 Reduced 2.35%	360,405 $3.47 Million
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $1.22 Million - $1.54 Million	-123,824 Reduced 25.12%	369,077 $4.45 Million
Q3 2021 Nov 12, 2021	BUY	$8.74 - $11.84 $2.09 Million - $2.84 Million	239,534 Added 94.54%	492,901 $4.77 Million
Q2 2021 Aug 12, 2021	BUY	$8.71 - $10.72 $2.21 Million - $2.72 Million	253,367 New	253,367 $2.67 Million

Others Institutions Holding FOLD

# of Institutions

283

Shares Held

321M

Call Options Held

260K

Put Options Held

261K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3.15B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account